Abiopharma

🔍 Thompson Michael N. Jr. (Director)

Company: Joby Aviation, Inc. (JOBY)

Report Date: 2026-06-02

Detailed Transactions and Holdings:

• Acquired 19,157 shares of Common Stock (Direct)
  Date: 2026-06-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,575,625.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-02 | Code: H | nature_of_ownership: Reinvent Sponsor LLC | shares_owned_after: 17,130,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-02 | Code: H | nature_of_ownership: Child 1 | shares_owned_after: 550.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-02 | Code: H | nature_of_ownership: Child 2 | shares_owned_after: 550.00 | Footnotes: F3
• Sold 19,157 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-06-02 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4, F4
• Acquired 18,850 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-06-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,850.00 | transaction_form_type: 4 | Footnotes: F5, F5

Footnotes:

• F1: The Reporting Person elected to defer receipt of the shares in accordance with the Issuer's Non-Employee Director Compensation Program.
• F2: The securities are directly held by Reinvent Sponsor LLC ("Sponsor"). The Reporting Person may be deemed a beneficial owner of securities held by Sponsor by virtue of his shared control over and indirect pecuniary interest in Sponsor. The Reporting Person disclaims beneficial ownership of the securities held by Sponsor, except to the extent of his pecuniary interest therein.
• F3: Reflects shares in a custodial account for the child of the Reporting Person established pursuant to the Uniform Transfer to Minors Act, for which the Reporting Person serves as a custodian. The Reporting Person disclaims beneficial ownership of these shares.
• F4: Represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors (the "2025 Annual Award"). The 2025 Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 6, 2026, in each case, subject to Reporting Person's continued status as a Service Provider (as defined in the Issuer's 2021 Incentive Award Plan) through the applicable vesting date. Each RSU represents a contingent right to receive one share of Common Stock upon vesting.
• F5: Represents an annual award of restricted stock units ("RSUs") to the Issuer's non-employee directors (the "2026 Annual Award"). The 2026 Annual Award shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 2, 2027, in each case, subject to Reporting Person's continued status as a Service Provider (as defined in the Issuer's 2021 Incentive Award Plan) through the applicable vesting date. Each RSU represents a contingent right to receive one share of Common Stock upon vesting.